FindTrial
Sign In

Establishment and validation of Premonitory model of deterioration of the 2019 novel corona virus pneumonia (COVID-19)

Establishment and validation of Premonitory model of deterioration of the 2019 novel corona virus pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030799
Enrollment
Unknown
Registered
2020-03-15
Start date
2020-01-20
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Gold Standard:Clinical outcome
Index test:artificial&#32
intelligence&#32
prediction&#32
model

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who were confirmed diagnosis of COVID-19 pneumonia, according to the "pneumonia diagnosis and treatment program for novel coronavirus infection (trial version seven)", including clinical symptoms, pulmonary CT manifestations and positive nucleic acid test; 2. Patients who admitted to the designated hospitals.

Exclusion criteria

Exclusion criteria: 1. Previous medication information was not recorded; 2. The patients' medical records were incomplete after admission.

Design outcomes

Primary

MeasureTime frame
cure rate;propotion of progression;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactTAO WANG

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

wt7636@126.com+86 13971477320

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026